Home » Emerson and Optimal Join Forces to Produce a Full PAT Solution for Life Sciences Industries
Emerson and Optimal Join Forces to Produce a Full PAT Solution for Life Sciences Industries
Emerson Process Management and Optimal Industrial Automation Ltd have formed an alliance that integrates Optimal’s synTQ PAT data management package with Emerson’s PlantWeb digital plant architecture. The alliance delivers a Process Analytical Technology (PAT) solution that leverages existing automation investments and has the scalability to deliver stand-alone PAT solutions for R&D labs, or deliver an integrated DeltaV or Syncade PAT solution for manufacturing floors.
“Emerson now has a full PAT solution,” said Saroj Patnaik, director, life sciences, from Emerson’s global industry solutions group. “Global trends like changing disease profiles, the increasing aging population and government run health care will demand more-for-less manufacturing methods. Producing more safe products in smaller quantities across the world in a cost effective manner is a daunting task for our customers. We believe PAT has the promise to be the holy grail of real-time release of products. The Emerson/synTQ alliance will help our customers meet these cost pressures by leveraging their existing automation investment.”
The synTQ data management package, in concert with DeltaV automation system, monitors the manufacturing process holistically and adjusts the process to continually optimize product quality. This technology requires both accurate and real-time information as to how critical-to-quality product attributes are varying as the process progresses, and adjusts the process to continually optimize these parameters. Optimal’s synTQ software product collects real-time instrument analytical data together with the control system’s univariate data and derives the necessary critical-to-quality product information in real-time. The trends in this critical-to-quality information can then be used by synTQ and the control system to steer the process to improve product quality together with timely manufacturing execution.
“We are gratified to have this formal alliance in place with Emerson,” said Martin Gadsby, director of Optimal Industrial Automation. “This alliance is a good fit for us. This alliance expands the synTQ package with a global sales and support capability from Emerson. Additionally, synTQ provides our clients with a best-in-class PAT Data Management System with the full support of Emerson. Our projected development path for the synTQ package is to more tightly integrate it with Emerson’s PlantWeb architecture. The important value to the customer is its ability to integrate seamlessly to customers’ preferred analytical instruments and lab systems.
About Emerson Process Management
Emerson Process Management (www.emersonprocess.com), an Emerson business, is a leader in helping businesses automate their production, processing and distribution in the chemical, oil and gas, refining, pulp and paper, power, water and wastewater treatment, mining and metals, food and beverage, pharmaceutical and other industries. The company combines superior products and technology with industry-specific engineering, consulting, project management and maintenance services. Its brands include PlantWeb, Syncade, Fisher, Rosemount, Micro Motion, Daniel, DeltaV, Ovation, and AMS Suite.
Emerson (NYSE:EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions to customers through its network power, process management, industrial automation, climate technologies, and appliance and tools businesses. Emerson’s sales in fiscal 2009 were $20.9 billion. The company is ranked 94th on the Fortune 500 list of America’s largest companies. For more information, visit www.Emerson.com.
About Optimal Industrial Automation
Established over 22 years ago, Optimal is a leading UK based company focused on factory and process automation with specialties in the life sciences, chemical, food & beverage plus power generation industries including nuclear, energy from waste and CHP. Having innovation at its heart with a strong desire to help clients optimize their processes, Optimal embarked on the development of a product specifically for enabling Process Analytical Technology in a regulated environment. Continuous innovation and development by a dedicated team over an 8 year period has resulted in the industry leading PAT Data Management software package – synTQ. synTQ is the most mature product in this market space and an active development plan will ensure it retains its lead.
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business
Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market
Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online
Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report
CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM
CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding
Biosimilars Market Prediction Up 20 Percent from 2012From Drug Store News
New report forecasts global $2.445 billion market this year
Cholesterol Drugs Could Help Kidney Cancer SurvivalFrom HealthDay News
Study finds statin medications tied to lower death risk after nearly four years of follow-up
Thermo Fisher Scientific Launches Online Configuration ToolFrom Thermo Fisher Scientific
iAutomate software reduces time needed for optimal system set-up design and provides accurate estimates
- All news »